Increased serum levels of advanced glycation end-products and diabetic complications

被引:119
作者
Ono, Y
Aoki, S
Ohnishi, K
Yasuda, T
Kawano, K
Tsukada, Y
机构
[1] Sapporo Shakaihoken Gen Hosp, Dept Internal Med, Atsubetsu Ku, Sapporo, Hokkaido 004, Japan
[2] Special Reference Labs, Tokyo, Japan
关键词
advanced glycation end-product (AGE); diabetic complications; renal function; diabetic retinopathy; blood sugar control;
D O I
10.1016/S0168-8227(98)00074-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We determined serum advanced glycation end-products (AGE) levels in patients with NIDDM and evaluated the relationship between these levels and diabetic complications. The subjects consisted of 125 patients (mean age, 59.2 +/- 11.1 years, duration of diabetes 11.6 +/- 8.9 years, mean HbA(1c), 6.8 +/- 1.0%) with stable blood sugar control. Sixty-three healthy volunteers (mean age, 58.3 +/- 12.7 years) served as controls. Serum AGE were measured by a newly developed ELISA method. Serum AGE levels were significantly higher in the diabetic group compared with the normal control group (7.2 +/- 14.6 vs. 3.3 +/- 1.0 mU/ml, P < 0.05),Significant correlations were seen between serum AGE and the degree of diabetic nephropathy. Serum AGE levels of diabetic patients with proliferative retinopathy were significantly higher than those of patients without proliferative retinopathy (5.7 +/- 1.8 vs. 3.1 +/- 1.0 mU/ml, P < 0.025) in the patient groups whose serum creatinine levels were between 2.0 and 3.9 mg/dl, although serum creatinine levels of both groups were not significantly different. Serum AGE levels reflected the severity of diabetic complications, including nephropathy and retinopathy. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:131 / 137
页数:7
相关论文
共 15 条
[11]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986
[12]   NON-ENZYMATIC GLYCOSYLATION OF PERIPHERAL-NERVE PROTEIN IN DIABETES-MELLITUS [J].
VLASSARA, H ;
BROWNLEE, M ;
CERAMI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08) :5190-5192
[13]   ADVANCED GLYCATION END-PRODUCTS INDUCE GLOMERULAR SCLEROSIS AND ALBUMINURIA IN NORMAL RATS [J].
VLASSARA, H ;
STRIKER, LJ ;
TEICHBERG, S ;
FUH, H ;
LI, YM ;
STEFFES, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11704-11708
[14]  
YAMADA K, 1994, CLIN NEPHROL, V42, P354
[15]   ADVANCED GLYCATION END-PRODUCTS UP-REGULATE GENE-EXPRESSION FOUND IN DIABETIC GLOMERULAR-DISEASE [J].
YANG, CW ;
VLASSARA, H ;
PETEN, EP ;
HE, CJ ;
STRIKER, GE ;
STRIKER, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9436-9440